Catalent
CTLT
#1737
Rank
NZ$19.94 B
Marketcap
NZ$109.88
Share price
0.00%
Change (1 day)
15.86%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Catalent (CTLT) - Total assets

Total assets on the balance sheet as of September 2024 : NZ$16.80 Billion

According to Catalent's latest financial reports the company's total assets are NZ$16.80 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Catalent - Total assets on balance sheet (from 2013 to 2024)

Total assets by year

Year Total assets Change
2023-06-30NZ$17.57 B4.34%
2022-06-30NZ$16.83 B29.3%
2021-06-30NZ$13.02 B8.03%
2020-06-30NZ$12.05 B31.06%
2019-06-30NZ$9.19 B37.47%
2018-06-30NZ$6.69 B41.81%
2017-06-30NZ$4.71 B8.93%
2016-06-30NZ$4.33 B-6.32%
2015-06-30NZ$4.62 B31.12%
2014-06-30NZ$3.52 B-7.49%
2013-06-30NZ$3.81 B-2.55%
2012-06-30NZ$3.91 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Supernus Pharmaceuticals
SUPN
NZ$2.45 B-85.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
NZ$0.65 B-96.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
NZ$19.65 B 16.98%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Intercept Pharmaceuticals
ICPT
NZ$0.68 B-95.95%๐Ÿ‡บ๐Ÿ‡ธ USA